KOSDAQ-Listed Union Korea Pharm Issues Paid-In Capital Increase... Third-Party Allotment to Bukwang Pharmaceutical
Union Korea Pharm, a KOSDAQ-listed company, announced on the 18th that it has decided to issue new shares through a third-party allotment paid-in capital increase.
Hot Picks Today
"Annual Average Sales Exceed 7.5 Billion Won": Olive Young in This Area Far Outperforms Even Seoul
- "Banks Roll Out 'High-Interest Specials' Offering Up to 7-13% a Year: 'Why Not Choose Savings Over Stocks?'"
- Soojung Lee Raises Doubts about Jang Miran's Cause of Death: "A Young Woman Hanging Herself from a Palm Tree at Night? That's Laughable"
- "Even If It Costs More Than the Drink... Chinese Millennials and Gen Z Drive Trend for 'Stickers' Pricier Than Beverages"
- Asia's Greatest Beauty, "Click," and the Mystery Graffiti...What I Learned Looking for "Kim Jimi" [Unstagram]
A total of 60 million new common shares will be issued at 500 won per share. The third-party allotment recipient is Bukwang Pharmaceutical Co., Ltd. (60 million shares).
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
